Approval · Notice of Compliance 5637 · 1994

SABRIL: Notice of Compliance 5637

Issued January 14, 1994

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 5637
Date: January 14, 1994
Company: Marion Merrell Dow (Canada) Inc.Laval, Quebec, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Other
Therapeutic class: Anti-epileptic

Products in this notice

Brand	DIN	Status today
SABRIL	02065819	Marketed
SABRIL	02068028	Cancelled Pre Market
SABRIL	02068001	Cancelled Pre Market
SABRIL	02067994	Cancelled Pre Market
SABRIL	02068036	Marketed

Medicinal ingredients

VIGABATRIN 500 MG per TAB
VIGABATRIN 1 G per PCK
VIGABATRIN 2 G per PCK
VIGABATRIN 3 G per PCK
VIGABATRIN 0.5 G per PCK